Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | SRC | P12931 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.46 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL502830 | 1.00 | DPP4 (0.52) | DPP4CYP2D6SRCLMNAMAPK1 | |
| SCHEMBL43670 | 1.00 | DPP4 (0.52) | DPP4CYP2D6SRCLMNAMAPK1 | |
| SCHEMBL29360215 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Hydrochloric Acid SCHEMBL4799572 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Hydrochloric Acid SCHEMBL7582981 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Hydrochloric Acid SCHEMBL9445669 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Methane SCHEMBL29238636 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Carbamic Acid SCHEMBL29625257 | 0.96 | CYP2D6 (0.48) | DPP4CYP2D6SRCLMNAMAPK1 | |
| SCHEMBL7103757 | 0.88 | LMNA (0.45) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Trifluoroacetic Acid SCHEMBL918979 | 0.88 | SLC1A3 (0.44) | DPP4CYP2D6SRCLMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2881 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719498-A1 | RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| EP-4719486-A1 | CONJUGATES AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| US-12540161-B2 | Linkers | BICYCLETX LIMITED (GB) | 2026-02-03 | — | — | US | claimed |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| US-20250332223-A1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | UNIV MIAMI (US) | 2025-10-30 | — | — | US | claimed |
| US-20250277012-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS, INC. | 2025-09-04 | — | — | US | claimed |
| US-20250250298-A1 | ONCOLYTIC PEPTIDE AND USE THEREOF | RISE BIOPHARMACEUTICALS INC. (CN) | 2025-08-07 | — | — | US | claimed |
| US-12377135-B2 | GHRH antagonists for use in a method of treating sarcoidosis | UNIVERSITY OF MIAMI (US) | 2025-08-05 | — | — | US | claimed |
| US-20250186539-A2 | METHODS FOR TREATING CANCER | BICYCLETX LIMITED (GB) | 2025-06-12 | — | — | US | claimed |
| US-20250171776-A1 | NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY | SAREPTA THERAPEUTICS, INC. (US) | 2025-05-29 | — | — | US | claimed |
| WO-2004056871-A2 | PEPTIDES AND THEIR USE FOR THE TREATMENT OF HIV INFECTIONS | IPF PHARMACEUTICALS GMBH (DE) | 2004-07-08 | — | — | WO | claimed |
| US-6653295-B2 | Protease inhibitor; viricide | BRISTOL-MYERS SQUIBB COMPANY | 2003-11-25 | — | — | US | claimed |
| WO-2003064458-A2 | NOVEL PEPTIDE DERIVATIVES, PREPARATION AND THERAPEUTIC AND COSMETIC APPLICATION THEREOF | INSTITUT EUROPEEN DE BIOLOGIE CELLULAIRE (FR) | 2003-08-07 | — | — | WO | claimed |
| US-20030100768-A1 | Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors | BRISTOL-MYERS SQUIBB COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2003-05-29 | — | — | US | claimed |
| US-20030064962-A1 | Inhibitors of hepatitis C virus NS3 protease | BRISTOL-MYERS SQUIBB COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2003-04-03 | — | — | US | claimed |
| US-20020177725-A1 | Peptide inhibitors of hepatitis C virus NS3 protein | BRISTOL-MYERS SQUIBB COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2002-11-28 | — | — | US | claimed |
| WO-2002048116-A2 | INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-06-20 | — | — | WO | claimed |
| WO-2002048157-A2 | IMIDAZOLIDINONES AND THEIR RELATED DERIVATIVES AS HEPATITIS C VIRUS NS3 PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-06-20 | — | — | WO | claimed |
| WO-1993015042-A1 | PROCESS FOR THE PREPARATION OF D(-) AND L(+)-3,3-DIPHENYLALANINE AND D(-) AND L(+)-SUBSTITUTED 3,3-DIPHENYLALANINES AND DERIVATIVES THEREOF | WARNER-LAMBERT COMPANY (US) | 1993-08-05 | — | — | WO | claimed |
| US-5198548-A | Chemical intermediates for angiotensins | WARNER-LAMBERT COMPANY (US) | 1993-03-30 | — | — | US | claimed |